14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma

Molecular Cancer Therapeutics
Huiling YangMong-Hong Lee

Abstract

The 14-3-3sigma gene product, up-regulated by p53 in response to DNA damage, is involved in cell-cycle checkpoint control and is a human cancer epithelial marker down-regulated in various tumors. However, its role and function have not been established in nasopharyngeal carcinoma (NPC), a tumor of epithelial origin. Recently, we found that 14-3-3sigma interacts with p53 in response to DNA damage and stabilizes the expression of p53. In addition, we also showed that overexpression of 14-3-3sigma inhibits oncogene-activated tumorigenicity. In the present study, we investigated the tumor-suppressive role of 14-3-3sigma in NPC cells. We found that there is a failure to up-regulate 14-3-3sigma in response to DNA damage in two NPC cell lines that have p53 mutation. We also found that 14-3-3sigma interacted with protein kinase B/Akt and negatively regulated the activity of Akt. Overexpression of 14-3-3sigma inhibited NPC cell growth and blocks DNA synthesis. Overexpression of 14-3-3sigma also led to inhibition of anchorage-independent growth of NPC cells. In addition, we found that 14-3-3sigma sensitized NPC cells to apoptosis induced by the chemotherapeutic agent 2-methoxyestradiol. Overexpression of 14-3-3sigma in both NPC cell line...Continue Reading

References

Apr 1, 1995·Human Pathology·L F SheuC L Meng
Jan 1, 1993·Epidemiologic Reviews·A Hildesheim, P H Levine
Mar 15, 1997·Genes & Development·S G KennedyN Hay
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C HeB Vogelstein
Jul 11, 1998·Molecular Cell·H HermekingB Vogelstein
Sep 15, 1999·Nature·J A Romashkova, S S Makarov
May 17, 2000·Proceedings of the National Academy of Sciences of the United States of America·A T FergusonS Sukumar
Jun 1, 2001·The Journal of Biological Chemistry·O AprelikovaE T Liu
Nov 21, 2001·Nature Cell Biology·B P ZhouM C Hung
Jun 4, 2002·The Journal of Biological Chemistry·Naoya FujitaTakashi Tsuruo
Sep 24, 2002·Nature Medicine·Jiyong LiangJoyce M Slingerland
Nov 27, 2002·Seminars in Cancer Biology·Mimi C Yu, Jian-Min Yuan
Oct 1, 2003·Molecular and Cellular Biology·Heng-Yin YangMong-Hong Lee
Mar 18, 2004·International Journal of Cancer. Journal International Du Cancer·Lillian Shuk-Nga ChowDolly P Huang

❮ Previous
Next ❯

Citations

Nov 19, 2011·Cancer Metastasis Reviews·Seyed Mehdi Jafarnejad, Gang Li
Jan 4, 2007·Molecular Cancer·William Chi-Shing Cho
Jan 3, 2014·Oral Oncology·Hana PolanskaMichal Masarik
Jul 17, 2015·Nature Communications·Liem PhanMong-Hong Lee
Oct 26, 2012·Cell Cycle·Chieh-Lin TengMong-Hong Lee
Feb 27, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Debmalya RoyLi Sun
Dec 21, 2018·Current Molecular Pharmacology·Lisha XieWeiguo Huang
Jun 5, 2016·The Journal of Biological Chemistry·Kumarkrishna RaychaudhuriSorab N Dalal
May 10, 2017·Cancer Biomarkers : Section a of Disease Markers·Zhenjie YangShusen Zheng
Dec 9, 2020·Pharmaceuticals·Ghazi Aljabal, Beow Keat Yap
Sep 21, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yun HuangWeiguo Huang
Jul 1, 2021·Journal of Thrombosis and Haemostasis : JTH·Bal Krishan SharmaJoseph S Palumbo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.